31 results about "Therapy vision" patented technology

An apparatus and method for preventing, controlling and / or treating vision disorders, such as eye fatigue and myopia, comprises a panel or a plurality of panels with a contrast stimulus or contrast stimuli presented to a peripheral vision or peripheral visions. A contrast stimulus may be a spatial frequency contrast, a luminance contrast, a translucency / transparency contrast, a depth contrast or a spectral contrast. The panel is configured to fit on screens, monitors, televisions, displays and the like. The panel may be adapted to fit on hats, glasses, the head, and the like. The panel may be constructed to be portable and stand alone, to be used while viewing a primary object, such as a visual display monitor, a book, or the like.

Disclosed is a computer-implemented method for correcting refractive errors in a living eye using a laser vision correction system that involves first calculating an amount of sphere based on preoperative manifest refraction and higher order aberrations data associated with the eye, and then correcting for the calculated amount of sphere by ablating at least a portion of the eye. The preoperative manifest refraction may include preoperative manifest sphere, preoperative spherical equivalent, regular astigmatism, and oblique astigmatism, and the preoperative higher-order aberrations may include 4th-order spherical and 3rd root mean square. Other factors may also be used to adjust the calculated amount of sphere. A device readable medium for storing the calculation and instructions for operating a laser vision correction system for practicing the method is also disclosed, as is a method of treating refractive errors.

Described herein are improved systems and methods for diagnosis and therapy of vision stability dysfunctions in a patient. One embodiment provides a device (1) for obtaining data from a patient (3). Device (1) includes a frame (5) configured for mounting to the patient (3), a target module (8) for providing a drive signal to define a selectively movable target object, an eye tracking module (12) mounted to the frame (5), the module (12) being responsive to the drive signal for obtaining first data indicative of one or more characteristics of the patient's eyes; and a head tracking module (16) mounted to the frame (5), the head tracking module (16) being responsive to the drive signal for obtaining second data indicative of one or more characteristics of the motion of the patient's head.

An ophthalmic surgical device is disclosed that combines laser energy for treatment of vision or ocular defect and illumination energy for visualization of a treatment site during surgery in a single common waveguide fiber, thereby enabling reduction of a diameter of a probe or canula of the device, whereby a smaller incision may be utilized to reduce trauma to the eye. The device may further include additional features, such as a conduit for supply of material or removal of material from the treatment site.

This invention is in the field of the treatment of eye disorders. In particular, it relates to the use of a remote monitoring system for determining patient response to therapeutic treatment, in particular with VEGF antagonists.

The invention relates to an eye drop used for releasing eye fatigue and a preparation method thereof. The eye drop comprises following raw materials: radix rehmanniae, rhizoma atractylodis, crab grass, serissa japonica, jasmine, red-spotted stonecrop, wolfberry, astragalus smicus, python gall, cocklebur, chamomile, concha haliotidis, Taiwan beautyberry, globe amaranth, pearl and weathered sodium sulfate powder. The eye drop is a pure traditional Chinese medicine preparation; is prepared by modern advanced pharmaceutical technologies; has efficacies of clearing away heat and purging pathogenic fire, relieving spasm and removing eyewinker, and nourishing the liver and improving visual acuity; and can be used for treating diminution of vision and pseudomyopia of teenagers, and reliving visual fatigue of eyes, and symptoms caused by visual fatigue such as conjunctival injection and eye itch. Compatibility of the selected raw materials is appropriate, curative effects are significant, safety performance is excellent, no side effects exist, cost is low, and the eye drop is worth of wide popularization and application.

Method and system for treating of visual impairment associated with misalignment between eyes of a patient is described. The invention allows to obtain electronically of an image of an object at which one eye of the patient is staring, calculating angular deviation between staring direction of this eye and the second eye and displaying before the second eye the image after it has been electronically processed so as to correct the angular deviation and to obtain the image, which would be perceptible by the brain as a single three dimensional stereoscopic image.

The present disclosure provides a gaming system including an application that can be implemented using a dynamic testing game, wherein the system does not require glasses, goggles, or any other headwear. The system enables a test subject to be screened and treated for vision dysfunctions while engaging with a dynamic video game.

An electrotherapeutic device for treating a visual disease using microcurrent stimulation is provided. The device includes a signal generator in which a waveform controller digitally controls a waveform signal source so as to generate a waveform in which one or more waveform parameters (e.g., pulse width, pulse period, pulse position, pulse coding, peak current amplitude, duty cycle, and / or pulse shape) are varied in accordance with a protocol for treating a visual disease. The device also includes an applicator connected to the signal generator and configured to apply the waveform to at least one stimulation point within an eye region.

The eyesight improving instrument to guide medicine liquid to human eye to treat eye diseases includes a pulse generator and positive and negative electrode plates. The pulse generator includes a vibration pulse generating circuit, a vibration pulse amplifying and outputting circuit, and a timing control circuit. The vibration pulse generating circuit includes two pulse vibrators, each of which comprises a voltage compressor and resistors, capacitors and other electronic elements; and one third voltage comparator, which accepts two square wave signals of frequency of 3500-4500 Hz and 35-100 Hz separately from the two pulse vibrators to generate harmonics of 35-4500 Hz frequency. The harmonics is then amplified in the vibration pulse amplifying and outputting circuit to 100-1000 mV amplitude, and the amplified harmonics are coupled to the electrode plates. The timing control circuit controls the operation time of the vibration pulse generating circuit.

The invention relates to the technical field of medical care, and in particular relates to a vision detection and treatment method and a vision detection and treatment device. According to the invention, the vision detection and treatment method comprises a vision detection method and a vision treatment method, and the vision can be treated while being detected; according to the vision detection and treatment device, a vision detection device is combined with a vision treatment device, so that a closed cycle is formed, therefore, the vision can be treated while being detected, meanwhile, the vision treatment result can be displayed, thus a user can clearly know the promotion condition of the vision during the myopia treatment process, and further, the user has the eye exercising perseverely. Meanwhile, the device is a small wearable device in the shape similar to that of glasses, people can use the device to know the vision condition anytime and anywhere and receive treatment in the daily life, therefore, the use is convenient, and the device is particular suitable for use by families and individuals.

Implementation of the present invention takes place in association with the utilization of one or more processed products produced from the Indian Mulberry plant, scientifically known as Morinda citrifolia L., to treat one or more eye disorders that affect vision, such as glaucoma, diabetic retinopathy, retinitis pigmentosa, cataracts, age-related macular degeneration, night blindness, color blindness, and other related conditions. The processed Morinda citrifolia products from the Indian Mulberry plant may be in the form of a dietary supplement, eye drops, or in another suitable form.

This disclosure relates to a composition for the prevention or the treatment of visual impairments comprising ursodeoxycholic acid (UDCA). More particularly, this disclosure relates to an=pharmaceutical composition for the prevention or the treatment of visual impairments such as macular degeneration, glaucoma and diabetic retinopathy which can be formulated for an oral administration, an intravitreal injection, or an eye drop administration by aqueous solubilized UDCA.

The invention belongs to the technical field of traditional Chinese medicines and particularly relates to a medicinal eye patch for treating blurred vision and a preparation method of the medicinal eye patch. The medicinal eye patch consists of an eye patch body with cavities and a traditional Chinese medicinal component putted in the cavities of the eye patch body. The traditional Chinese medicinal component is prepared from the following raw materials in parts by weight: 30 to 50 parts of cape jasmine fruit, 16 to 30 parts of radix et rhizoma rhei, 16 to 30 parts of radix curcumae, 30 to 50parts of rhizoma coptidis, 16 to 30 parts of radix scutellariae, 18 to 35 parts of airpotato yam rhizome, 18 to 35 parts of oriental stephania root, 15 to 30 parts of myrrh, 25 to 40 parts of concha haliotidis, 25 to 40 parts of semen cassiae and 30 to 50 parts of mulberry leaves. The medicinal eye patch has the advantages of reasonable formula, simple pharmacy process, low cost, high penetrationcapability, quick absorption, bacteria resistance, inflammation elimination and obvious effects of promoting circulation and removing stasis. The medicinal eye patch can promote regeneration of bloodvessels in crystals and enables patients with the blurred vision to be cured; in addition, a product is an external pure traditional Chinese medicinal product and is convenient to use, pollution-freeand convenient to carry; besides, a medicine can directly act eye parts without metabolism of spleen and liver of a human body and quickly takes effect without side effects.

The invention discloses a liver nourishing and kidney tonifying preparation for improving decreased vision of high school students. The preparation is prepared from, by weight, 9-13 parts of Rhizoma Alismatis, 6-14 parts of Philippine flemingia root, 7-12 parts of Flower of Chinese hibiscus, 9-14 parts of Cynanchum bungei Decne, 8-13 parts of Herba Centipedae, 7-14 parts of root of Chinese Mahonia, 10-15 parts of Psychotria siamica (Craib) Hutch., 11-17 parts of wolfberry fruit, 6-12 parts of Achyranthes aspera, 8-14 parts of Gentiana apiata N. E. Brown, 9-15 parts of turnip flower, 6-13 parts of Digitaria sanguinalis (L.) Scop., 8-15 parts of Radix Polygalae and 9-12 parts of Pleioblastus amarus. The liver nourishing and kidney tonifying preparation is prepared from common traditional Chinese medicinal materials, and has the advantages of wide medicine sources, low price, realization of yin nourishing, internal heat eliminating, blood cooling, detoxifying, liver clearing and eyesight improving efficacy through compatibility of above medicines, substantial treatment effect on the decreased vision, and effective alleviation of eye fatigue, amblyopia and other eye diseases in a short time.

Described herein are methods and pharmaceutical compositions for the prevention and / or treatment of visual impairment and vision loss, and more particularly to the use of DAN family BMP antagonist(s) for the prevention of ocular neovascularization and, as a trophic factor for photoreceptors in eye diseases. Also described is a method for long-term inhibition of neovascularization in an ocular condition, a method of replacement therapy for vascular endothelial growth factor (VEGF) inhibitor treatment and a method for inhibiting and / or preventing ocular neovascularization and / or ocular angiogenesis in a mammalian subject, the methods comprising administering to a mammalian subject in need an effective amount a DAN family BMP antagonist such as DAND5.

The invention discloses a liquid preparation for treating visual impairment and injury. The liquid preparation is prepared from blueberry juice powder, lutein ester, zeaxanthin, a grape seed extract, haematococcus pluvialis, vitamin C and taurine. All the raw material components cooperate and act together, free radicals in retina can be effectively removed, blood circulation of blood capillaries around eyes can be improved, absorption of eye nutrition can be promoted, visual impairment and injury can be effectively treated, asthenopia can be eliminated, clear vision can be kept, and xerophthalmia can be relieved. In addition, the liquid preparation can effectively improve muscae volitantes, cataract, glaucoma and macular degeneration.

A nutritional or dietary supplement composition that strengthens and promotes a general eye health benefit for aging adults, including retinal health through the prevention, stabilization, reversal and / or treatment of visual acuity loss by reducing the risk of developing late stage or advanced age-related macular degeneration in persons with early age-related macular degeneration. The nutritional or dietary supplement composition may likewise reduce the risk of vision loss associated with the development of cataracts.